Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical needs. They develop computational methods for protein design that leverage machine learning and quantum computing.

Biotechnology

Menten AI

Menten AI's headquarters in Palo Alto, CA, United States

Hans Melo

Stephan Kudlacek

Andrea McNeal

Patrick Finneran

Christy H. Wellman

Yvonne Angell

Vikram Mulligan

John Baldoni

Armand B. Cognetta III

The Leadership Team at Menten AI drives strategic direction and oversees the integration of cutting-edge technologies in drug discovery. Comprising the CEO, CFO, and Academic Co-founders, this team cultivates partnerships, secures funding, and ensures alignment with the company's mission to develop innovative peptide therapies for unmet medical needs. Their expertise in both business and academia enables them to effectively navigate the challenges of the biotech landscape.

Leadership Team

The Scientific and Protein Design Team at Menten AI leverages advanced computational methods, including machine learning and quantum computing, to design novel peptides for drug discovery. They work collaboratively to identify promising therapeutic candidates for conditions with high unmet medical needs, integrating expertise in protein design, biophysics, and drug discovery.

Scientific and Protein Design Team

This department provides expert guidance and support across various business functions.

Advisory Services

This department focuses on the research and development of proteins through innovative design techniques.

Menten AI

Org chart

Board & advisors

Teams

Leadership Team

Scientific and Protein Design Team

Advisory Services

Protein Design

Offices

Menten AI

Org chart

Board & advisors

Teams

Leadership Team

Scientific and Protein Design Team

Advisory Services

Protein Design

Offices

Related companies